Mr. Aubuchon serves as our Chief Commercial Officer and brings more than two decades of biopharmaceutical industry experience spanning leadership roles across global commercial and marketing functions including focus within the cardiometabolic space. Prior to joining Viking, Mr. Aubuchon was the chief commercial officer at AbCellera, where he was responsible for developing the company’s commercial strategy. Prior to AbCellera, he was the global marketing lead for Amgen’s general medicine early portfolio, where he developed the integrated strategy for the company’s non-oncology therapeutic areas and led commercial strategy for more than ten programs, including its cardiometabolic portfolio. Before his time at Amgen, Mr. Aubuchon spent nearly 17 years at Eli Lilly in various commercial roles including, chief marketing officer in Australia, chief marketing officer in Japan, head of strategy and operations for Lilly Bio-Medicines globally, and vice president of Lilly Bio-Medicines in Japan.